Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
MercadoLibre, Inc. stock logo
MELI
MercadoLibre
$1,355.19
0.0%
$1,720.56
$1,333.54
▼
$2,342.00
$68.78B1.42556,433 shs871,278 shs
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$37.87
-2.6%
$39.69
$35.12
▼
$64.16
$169.60B0.716.30 million shs8.98 million shs
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
$9.97
-5.7%
$15.89
$9.91
▼
$29.23
$7.95B-1.494.83 million shs4.77 million shs
Tyler Technologies, Inc. stock logo
TYL
Tyler Technologies
$405.47
+0.3%
$367.73
$270.71
▼
$481.57
$16.21B0.74751,470 shs345,819 shs
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
MercadoLibre, Inc. stock logo
MELI
MercadoLibre
-4.75%-8.11%-27.88%-29.50%-34.74%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
-1.52%-4.36%-1.11%-16.92%-20.74%
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
+0.67%-29.86%-34.31%-19.68%-36.17%
Tyler Technologies, Inc. stock logo
TYL
Tyler Technologies
-1.65%-4.56%+6.96%+15.20%-13.14%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
MercadoLibre, Inc. stock logo
MELI
MercadoLibre
$1,355.19
0.0%
$1,720.56
$1,333.54
▼
$2,342.00
$68.78B1.42556,433 shs871,278 shs
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$37.87
-2.6%
$39.69
$35.12
▼
$64.16
$169.60B0.716.30 million shs8.98 million shs
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
$9.97
-5.7%
$15.89
$9.91
▼
$29.23
$7.95B-1.494.83 million shs4.77 million shs
Tyler Technologies, Inc. stock logo
TYL
Tyler Technologies
$405.47
+0.3%
$367.73
$270.71
▼
$481.57
$16.21B0.74751,470 shs345,819 shs
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
MercadoLibre, Inc. stock logo
MELI
MercadoLibre
-4.75%-8.11%-27.88%-29.50%-34.74%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
-1.52%-4.36%-1.11%-16.92%-20.74%
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
+0.67%-29.86%-34.31%-19.68%-36.17%
Tyler Technologies, Inc. stock logo
TYL
Tyler Technologies
-1.65%-4.56%+6.96%+15.20%-13.14%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
MercadoLibre, Inc. stock logo
MELI
MercadoLibre
2.80
Moderate Buy$2,160.5959.73% Upside
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
2.00
Hold$59.4456.46% Upside
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
2.56
Moderate Buy$28.10182.38% Upside
Tyler Technologies, Inc. stock logo
TYL
Tyler Technologies
2.82
Moderate Buy$445.889.66% Upside

Current Analyst Ratings Breakdown

Latest MELI, NVO, TYL, and SMMT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/19/2026
MercadoLibre, Inc. stock logo
MELI
MercadoLibre
Lower Price TargetBuy$2,400.00 ➝ $2,000.00
11/18/2026
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
DowngradeMarket Perform ➝ Underperform$11.90 ➝ $8.30
11/18/2026
Tyler Technologies, Inc. stock logo
TYL
Tyler Technologies
Boost Price TargetBuy$450.00 ➝ $475.00
11/18/2026
Tyler Technologies, Inc. stock logo
TYL
Tyler Technologies
Reiterated RatingBuy$440.00 ➝ $500.00
11/16/2026
MercadoLibre, Inc. stock logo
MELI
MercadoLibre
Reiterated RatingPositive
11/16/2026
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
Lower Price TargetBuy$43.00 ➝ $42.00
11/16/2026
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
Lower Price TargetEqual Weight$20.00 ➝ $18.00
11/15/2026
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
Reiterated RatingBuy
11/11/2026
MercadoLibre, Inc. stock logo
MELI
MercadoLibre
Lower Price TargetNeutral$1,750.00 ➝ $1,600.00
11/9/2026
MercadoLibre, Inc. stock logo
MELI
MercadoLibre
Lower Price TargetNeutral$2,150.00 ➝ $1,850.00
11/5/2026
MercadoLibre, Inc. stock logo
MELI
MercadoLibre
Reiterated RatingStrong-Buy
(Data available from 11/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
MercadoLibre, Inc. stock logo
MELI
MercadoLibre
$28.89B2.37$52.77 per share25.63$161.75 per share8.36
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$46.80B3.62$4.52 per share8.41$7.51 per share5.06
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
N/AN/AN/AN/A$0.71 per shareN/A
Tyler Technologies, Inc. stock logo
TYL
Tyler Technologies
$2.33B6.93$12.30 per share33.06$70.18 per share5.79
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
MercadoLibre, Inc. stock logo
MELI
MercadoLibre
$2.00B$37.2836.2625.251.024.91%25.15%3.81%N/A
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$15.51B$3.979.5711.011.3633.99%53.52%19.49%2/3/2027 (Estimated)
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
-$1.08B-$1.07N/AN/AN/AN/A-138.82%-117.11%N/A
Tyler Technologies, Inc. stock logo
TYL
Tyler Technologies
$315.60M$7.9451.2132.902.7113.51%12.21%7.30%N/A

Latest MELI, NVO, TYL, and SMMT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/4/2026Q3 2026
MercadoLibre, Inc. stock logo
MELI
MercadoLibre
$9.27$8.83-$0.44$8.83$10.69 billion$10.75 billion
10/28/2026Q3 2026
Tyler Technologies, Inc. stock logo
TYL
Tyler Technologies
$3.48$3.52+$0.04$2.33$651.38 million$647.57 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
MercadoLibre, Inc. stock logo
MELI
MercadoLibre
N/AN/AN/AN/AN/A
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$0.822.11%+21.74%20.65%N/A
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
N/AN/AN/AN/AN/A
Tyler Technologies, Inc. stock logo
TYL
Tyler Technologies
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
MercadoLibre, Inc. stock logo
MELI
MercadoLibre
0.77
1.17
1.14
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
0.54
0.84
0.64
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
N/A
5.99
5.99
Tyler Technologies, Inc. stock logo
TYL
Tyler Technologies
0.51
1.33
1.33

Institutional Ownership

CompanyInstitutional Ownership
MercadoLibre, Inc. stock logo
MELI
MercadoLibre
87.62%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
11.54%
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
4.61%
Tyler Technologies, Inc. stock logo
TYL
Tyler Technologies
93.30%

Insider Ownership

CompanyInsider Ownership
MercadoLibre, Inc. stock logo
MELI
MercadoLibre
0.26%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
0.07%
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
81.80%
Tyler Technologies, Inc. stock logo
TYL
Tyler Technologies
1.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
MercadoLibre, Inc. stock logo
MELI
MercadoLibre
20,34750.70 million50.57 millionOptionable
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
69,5054.47 billion4.46 billionOptionable
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
265799.76 million145.56 millionOptionable
Tyler Technologies, Inc. stock logo
TYL
Tyler Technologies
7,80039.76 million39.32 millionOptionable

Recent News About These Companies

Tyler Technologies (NYSE:TYL) Stock Gets Price Target Increase from TD Cowen
Tyler Technologies (NYSE:TYL) COO Sells $4,196,900.00 in Stock

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
MercadoLibre stock logo

MercadoLibre NASDAQ:MELI

$1,355.19 -0.30 (-0.02%)
As of 03:52 PM Eastern
This is a fair market value price provided by Massive. Learn more.

MercadoLibre, Inc. operates online commerce platforms in the United States. It operates Mercado Libre Marketplace, an automated online commerce platform that enables businesses, merchants, and individuals to list merchandise and conduct sales and purchases digitally; and Mercado Pago FinTech platform, a financial technology solution platform, which facilitates transactions on and off its marketplaces by providing a mechanism that allows its users to send and receive payments online, as well as allows users to transfer money through their websites or on the apps. The company also offers Mercado Fondo that allows users to invest funds deposited in their Mercado Pago accounts; Mercado Credito, which extends loans to certain merchants and consumers; and Mercado Envios logistics solution that enables sellers on its platform to utilize third-party carriers and other logistics service providers, as well as fulfillment and warehousing services for sellers. In addition, it provides Mercado Libre Classifieds, an online classified listing service, where users can list and purchase motor vehicles, real estate, and services; Mercado Ads, an advertising platform, which enables large retailers and brands to promote their products and services on the web; and Mercado Shops, an online storefronts solution that enables users to set-up, manage, and promote their own digital stores. The company was incorporated in 1999 and is headquartered in Montevideo, Uruguay.

Novo Nordisk A/S stock logo

Novo Nordisk A/S NYSE:NVO

$37.87 -1.00 (-2.58%)
As of 03:52 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products; and with Korro Bio, Inc. for the discovery and development of new genetic medicines to treat cardiometabolic diseases. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Summit Therapeutics stock logo

Summit Therapeutics NASDAQ:SMMT

$9.97 -0.60 (-5.70%)
As of 03:52 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies in the United States, and the United Kingdom. The company's lead development candidate is Ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis; and anti-infectives portfolio includes SMT-738, a novel class of precision antibiotics for the treatment of multidrug resistant infections, which primarily includes carbapenem-resistant Enterobacteriaceae infections. It has a collaboration and license agreement with Akeso, Inc. and its affiliates to develop and commercialize ivonescimab, as well as strategic collaboration with The University of Texas MD Anderson Cancer Center for the purpose of accelerating the development of ivonescimab. The company was founded in 2003 and is headquartered in Miami, Florida.

Tyler Technologies stock logo

Tyler Technologies NYSE:TYL

$405.47 +1.31 (+0.32%)
As of 03:52 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Tyler Technologies, Inc. provides integrated information management solutions and services for the public sector. It operates in two segments, Enterprise Software and Platform Technologies. The company offers platform and transformative technology solutions, including cybersecurity for government agencies; data and insights solutions; digital solutions that helps workers and policymakers to share, communicate, and leverage data; payments solutions, such as billing, presentment, merchant onboarding, collections, reconciliation, and disbursements; platform technologies, an application development platform that enables government workers to build solutions and applications; and outdoor recreation solutions, including campsite reservations, activity registrations, licensing sales and renewals, and real-time data for conservation and park management. It also provides public administration solutions, such as civic services; financial applications with human resources, revenue management, tax billing, utilities, asset management, and payment processing; property and recording service that manages appraisal services, valuation, tax billing and collections, assessment administration, and land and official records; and permitting, licensing, and regulatory management solutions. In addition, the company offers courts and public safety solutions; school ERP and student transportation solutions for K-12 schools; and health and human services solutions. Further, the company offers software as a service arrangements and electronic document filing solutions for courts; software and hardware installation, data conversion, training, product modification, and maintenance and support services; and property appraisal outsourcing services for taxing jurisdictions. Tyler Technologies, Inc. has a strategic collaboration agreement with Amazon Web Services for cloud hosting services. The company was founded in 1966 and is headquartered in Plano, Texas.